National Committee for Blood Transfusion and Haemovigilance
Lebanese National Blood Bank Survey
Institution (Name, address):
Telephone:
Person assigned:
Email:
This survey has been created by the National Committee for Blood Transfusion and
Haemovigilance in order to collect blood transfusion quality indicators for the year 2013 and
to prepare the necessary data for the implementation of a haemovigilance system in Lebanon.
The following questions refer to your activity from January 1, 2013 to December 31, 2013.
Abbreviations:
TTI: transfusion transmitted infections
NAT: Nucleic acid testing
RIBA: Radio immuno-blot assay
Blood donors and blood collection:
1. Do you have a budget for donor recruitment?
2. Are donor retention strategies established?
3. Number and percentage of whole blood units collected:
Number
%
Collected at your blood
bank
Received from another
blood collection center
National Survey-committee for blood transfusionPage 1 of 9
National Committee for Blood Transfusion and Haemovigilance
4. The number of blood donors who donated whole blood or aphaeresis blood
components (excluding autologous donors):
Whole
blood
Number of voluntary
non-remunerated
blood donors
Apheresis
Donation
Total
First time
donor
Repeat
donors
Number of
family/replacement
donors or directed
donors
Total number of
donors
5. The number of donations collected based on the type of donation
(excluding autologous donations):
Whole blood
Voluntary nonremunerated
donations
Apheresis
donation
Total
First time
donor
Repeat donors
Family/replacement
donation or
directed donation
Total number of
donations
6. The number of potential blood donors who were deferred temporarily or permanently:
Number of permanent deferrals
Number of temporary deferrals
National Survey-committee for blood transfusionPage 2 of 9
National Committee for Blood Transfusion and Haemovigilance
7. Number of potential blood donors who were deferred from donating based on the
cause of deferral:
Low weight
Low Haemoglobin and/ or Hematocrit
Other laboratory reasons (WBC,
platelets…)
Other medical conditions
High risk behaviour
Travel history
Other reasons (Please Specify)
Total number of deferrals
% of total deferrals
8. Number of blood donations based on the gender of the donor:
Male donors
Female donors
9. Number of blood donations based on age group:
18 to 24 years
25 to 44 years
45 to 64 years
65 years or older
National Survey-committee for blood transfusionPage 3 of 9
National Committee for Blood Transfusion and Haemovigilance
10. Number of pre-deposit autologous blood donations:________
Screening for transfusion transmitted infections (TTI)
11. Do you confirm positive results for transfusion transmitted diseases?
Yes
No
12. If yes, the confirmatory tests performed are:
Yes
No
Western Blot (HIV)
RIBA (HCV)
Neutralisation (HBsAg)
NAT testing
Others
13. Is there a donor notification system in use for:
HIV test results
Yes
No
Hepatitis B test results
Yes
No
Hepatitis C test results
Yes
No
Syphilis test results
Yes
No
Other (please specify):
Yes
No
---------------------------------National Survey-committee for blood transfusionPage 4 of 9
National Committee for Blood Transfusion and Haemovigilance
14. Is a system established for post-donation counselling and referral to medical care for
follow up and treatment of the blood donors who tested positive for transfusion
transmitted infections?
Yes
No
15. Number and percentage of donations (whole blood and aphaeresis) who tested
positive for the following transfusion-transmissible infections:
Number
%
HIV 1+2
HBV
HCV
Syphilis
Anti-HBc Total
16. Prevalence (number and percentage) of HIV positive blood units based on type of
donations:
Number
Voluntary non remunerated
blood donations
%
First time donor
Regular donors
Family/replacement donations or
directed donations
17. Prevalence (Number and %) of HBV positive blood units by type of donations:
Number
Voluntary non remunerated
blood donations
%
First time donor
Repeat donors
Family/replacement donations or
National Survey-committee for blood transfusionPage 5 of 9
National Committee for Blood Transfusion and Haemovigilance
directed donations
18. Prevalence (Number and %) of HCV infections in donated blood units by type of
donations:
Number
Voluntary non remunerated
blood donations
%
First time donor
Repeat donors
Family/replacement donations or
directed donations
Blood component preparation
19. Prevalence (Number and %) of whole blood donations that are processed into blood
components:
Number
%
20. Number of specific units of blood components prepared from whole blood donations:
Number
Red cell preparations
Platelet concentrates
Fresh frozen plasma
Plasma
Cryoprecipitate
National Survey-committee for blood transfusionPage 6 of 9
National Committee for Blood Transfusion and Haemovigilance
21. The number of the various blood components collected through apheresis:
Apheresis red cells
Apheresis platelets
Apheresis plasma
22. The number of whole blood /blood component units discarded due to:
Incomplete blood donation
Reactive for TTI(s)
Expired
Storage problems
Transportation problems
Processing problems
Total
23. Number and percentage of blood donations that are:
Number
%
Leukocyte-reduced
at the blood bank
Leukocyte-reduced
at the patient
bedside
Not leukocytereduced
National Survey-committee for blood transfusionPage 7 of 9
National Committee for Blood Transfusion and Haemovigilance
Clinical use of blood & blood components:
24. Number of units of each of the following blood components issued /
transfused (excluding autologous blood units):
Whole blood
Plasma
Red cells
FFP
Platelets
Cryoprecipitate
25. Number of reported adverse transfusion reactions:
Immune-hemolytic transfusion reaction due
to ABO incompatibility
Immune-hemolytic transfusion reaction due
to other allo-antibody(s)
Non-immunologic haemolysis
Post-transfusion Purpura
Anaphylaxis/hypersensitivity
Febrile non-hemolytic transfusion reaction
Transfusion-related acute lung injury
(TRALI)
Graft versus host disease
Transfusion-associated HIV-1/2 infection
Transfusion-associated HBV infection
Transfusion-associated HCV infection
Sepsis due to bacterial contamination of the
blood/blood component unit
National Survey-committee for blood transfusionPage 8 of 9
National Committee for Blood Transfusion and Haemovigilance
Transfusion-associated malaria infection
Other transfusion-associated parasitical
infection
Transfusion-associated circulatory overload
Metabolic reaction
Other adverse transfusion reaction
Date:
Signature:
Definitions:
Apheresis: Procedure that involves sequential or continuous withdrawal of whole blood, ex
vivo separation, collection of the desired component (e.g. red cells, plasma or platelets) and
reinfusion of the other components.
Blood donors:
Voluntary non-remunerated blood donor: A person who donates blood (whole blood,
plasma or cellular components) of his/her own free will and receives no payment for it, either
in the form of cash, or in compensation which could be considered a substitute for money.
Family/replacement blood donor: A person who donates a replacement unit of whole
blood or blood component (apheresis platelets) only when a family member or friend requires
transfusion.
Autologous blood donor: A patient who donates his/her own blood to be stored and
infused, if needed, during surgery.
First time’ blood donor: An individual who has never donated before and donated blood
for the first time.
Regular donor: A blood donor who has donated more than once.
Fresh Frozen Plasma (FFP): A blood component prepared from whole blood or from
plasma collected by apheresis that is frozen within a specified time-lapse and stored at a
specified temperature that preserves the labile coagulation factors.
Adverse transfusion reaction: An undesirable response or effect in a patient associated with
the administration of blood or blood components that is fatal, life-threatening, disabling or
incapacitating or which results in, or prolongs, hospitalization or morbidity.
National Survey-committee for blood transfusionPage 9 of 9